Survey

Express Your Interest: Chronic Cough Patient-Focused Drug Development Meeting

We want to hear from you.

The Asthma and Allergy Foundation of America, COPD Foundation, Global Allergy & Airways Patient Platform, and Pulmonary Fibrosis Foundation are hosting an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on chronic cough in the Washington, D.C. on October 28, 2026.

This meeting is an opportunity for people to share their experiences directly with the U.S. Food and Drug Administration (FDA) and researchers who are working to develop new treatments. Your voice matters, and events like this one help ensure that the people most affected by chronic cough are heard throughout the drug development process.

If you are interested in attending or participating as a panelist, please fill out the form below. We will follow up with more information as the meeting details are finalized.

Please enter your contact information below.

First name:
Last name:
Email address:
City:
State/Province:
Country:

Which best describes your connection to chronic cough?

Check all that apply.

I am a person living with chronic cough
I care for someone living with chronic cough
I work at a patient advocacy organization or other nonprofit that supports people living with chronic cough
I work for a pharmaceutical or life sciences company
I am a health care professional who treats people with chronic cough
I am a researcher who studies chronic cough
I work for a government agency
Other (Please specify)